Ozempic Lawsuit: Litigation Update, Settlement Information, and Taking Action

Start
Many people who have taken Ozempic for weight loss are now taking legal action against the popular GLP-1 drug’s manufacturer. In numerous Ozempic lawsuits filed to date, plaintiffs allege that Novo Nordisk failed to adequately warn consumers of the risks associated with the weight loss drug—including risks for persistent vomiting, bowel obstruction, stomach paralysis, and vision loss….
By: Oberheiden P.C.
Previous Story

The Impact of Vocational Experts in Injury-Related Litigation

Next Story

CMS Issues Final Guidance on IPAY 2028 Drug Price Negotiation Program, 2026-28 MFP Effectuation